All-grade AEs by time period with asciminib. ∗Includes thrombocytopenia and platelet count decreased. †Includes neutropenia and neutrophil count decreased. ‡Includes anemia, hemoglobin decreased, and macrocytic anemia. §A patient with multiple occurrences of an AE is counted only once in that time period. Percentages were rounded to the nearest whole number. The denominator for incidence is the number of patients who were ongoing at the beginning of each time period who have not yet experienced the event. The denominator for prevalence is the number of patients who were ongoing at the beginning of each time period. ALT, alanine aminotransferase; AST, aspartate aminotransferase.